Tag: COVID-19 and MDS: Latest Updates

COVID-19 vaccines and MDS: Approvals and Advice – Updated 07/01/2022

MDS UK Note (12th January 2022): We have now received confirmation that CMML patients on treatment are also eligible to receive the treatments below. Updated 7th January 2022 The Department of Health and Social Care (DHSC) has issued a ‘Rapid Policy Statement’ regarding ‘Neutralising monoclonal antibodies or antivirals for patients with COVID-19’, for both hospitalised and […]

Read full story

How do COVID-19 vaccines work? Watch these animations!

A global vaccination drive against Covid-19 is underway, with governments, scientific experts, epidemiologists, and voluntary organisations all trying to get as many people immunised as possible. However, vaccine-hesitancy is still being noted among many people. So, the makers of the hit animated series Family Guy have produced a public service announcement and raise awareness about […]

Read full story

SOAP Study: How effective is the COVID Vaccine for MDS patients?

King’s College Hospital has been monitoring 38 MDS patients, as part of the SOAP study. The study has been measuring how effective the vaccines are in blood cancer patients and, specifically in these MDS patients, as initial results shown that COVID-19 vaccines may not be as effective in these patients as in the general population.

Read full story

Shielding for the Clinically Extremely Vulnerable has ended. What is the impact on working age blood cancer patients?

The repercussions of the government’s decision to end the shielding programme for Clinically Extremely Vulnerable (CEV) people are severe and multi-facetted. Most of the Clinically Extremely Vulnerable group, such as, for example, blood cancer patients, are still at very high risk of contracting COVID-19, as early research has indicated that the vaccines may not be […]

Read full story

New survey to evaluate antibody response in individuals with cancer

The National COVID Cancer Survey is evaluating antibody tests in individuals with cancer.  This is Phase 1 of a large nationwide NHS England project. It will evaluate finger prick COVID antibody testing in 10,000 individuals with cancer. Who is currently eligible to enter this trial? If you live in England, have been diagnosed with cancer in […]

Read full story

Be our hero! Join our 20:20 campaign and fundraise for MDS UK

2020 was a difficult time for everyone especially small charities. So 20 small charities came together to brainstorm and the result was to do 20 challenges over 20 days. For MDS UK the campaign proved immensely successful. 943 supporters and MDS patients raised £37,461 which allowed us to keep supporting MDS patients during the pandemics. […]

Read full story

COVID vaccine efficacy and MDS: In conversation with Dr Austin Kulasekararaj

On the 19th of July we had an informative conversation with Dr Austin Kulasekararaj, Consultant Haematologist, King’s College Hospital, London, on issues and concerns around COVID-19 “Freedom Day” and the efficacy of the Covid vaccine for MDS patients. Watch the video and read the excerpts below. “Obviously today is a big day, it’s called Freedom […]

Read full story

Important news for MDS patients: Government update for the extremely vulnerable, 3/6/2021

Full latest update online can be found here: https://www.gov.uk/government/publications/guidance-on-shielding-and-protecting-extremely-vulnerable-persons-from-covid-19/guidance-on-shielding-and-protecting-extremely-vulnerable-persons-from-covid-19 Below is the exact text provided by the government. Mainly, announcing that shielding is paused. However, we still advise to be extra cautious, whilst we wait for more robust results about the efficacy of the vaccines in blood cancer patients, and specifically MDS patients. The SOAP […]

Read full story
Free donations by shopping

Sign-up to Download our Free Patient Handbook!

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

MDS UK Patient Support Group will use the information you provide on this form to be in touch with you and to provide updates.